|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 205/57 | |
| C07D 301/32 | |||
| C07F 7/18 | |||
| C07C 51/347 |
| (11) | Number of the document | 2928858 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13812336.9 |
| Date of filing the European patent application | 2013-12-06 | |
| (97) | Date of publication of the European application | 2015-10-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/073474 |
| Date | 2013-12-06 |
| (87) | Number | WO 2014/089385 |
| Date | 2014-06-12 |
| (30) | Number | Date | Country code |
| 201261734672 P | 2012-12-07 | US | |
| 201361777882 P | 2013-03-12 | US |
| (72) |
HERING, Kirk William, US
CHAMBOURNIER, Gilles, US
ENDRES, Gregory William, US
FEDIJ, Victor, US
KRELL, Thomas James, II, US
MAHMOUD, Hussein Mahmoud, US
|
| (73) |
Cayman Chemical Company, Incorporated,
1180 E. Ellsworth Road, Ann Arbor, Michigan 48108,
US
|
| (54) | METHODS OF SYNTHESIZING A PROSTACYCLIN ANALOG |
| METHODS OF SYNTHESIZING A PROSTACYCLIN ANALOG |